Granulocyte-macrophage colony stimulating factor prior to chemotherapy for advanced epithelial ovarian cancer

被引：2
|
作者：
Guner, H
Oktem, M
Dilek, TUK
机构：
[1] Gazi Univ, Sch Med, Dept Obstet & Gynecol, Ankara, Turkey
[2] Baskent Univ, Sch Med, Dept Obstet & Gynecol, TR-06490 Ankara, Turkey
[3] Mersin Univ, Sch Med, Dept Obstet & Gynecol, Mersin, Turkey
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2003年 / 83卷 / 03期
关键词：
ovarian carcinoma; paclitaxel; cisplatin; GM-CSF; myelosuppression; chemotherapy;
D O I：
10.1016/S0020-7292(03)00296-0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：317 / 318
页数：2
相关论文
共 50 条
  • [41] Granulocyte-Macrophage Colony Stimulating Factor and Inflammatory Bowel Disease: Establishing a Connection
    Dranoff, Glenn
    GASTROENTEROLOGY, 2011, 141 (01) : 28 - 31
  • [42] The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion
    Liu, Qiqi
    Qiao, Lili
    Hui, Pingping
    Deng, Guodong
    Zhang, Jingxin
    Liang, Ning
    Xie, Jian
    Zhang, Jiandong
    JOURNAL OF BUON, 2017, 22 (01): : 21 - 28
  • [43] Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in elderly patients with primary acute myelogenous leukemia
    Gau, JP
    Ho, CH
    Hu, HT
    Young, JH
    Lin, TH
    Yang, Y
    Ho, KC
    ADVANCES IN THERAPY, 1998, 15 (03) : 151 - 157
  • [44] Use of granulocyte-macrophage colony stimulating factor in the treatment of prolonged haematopoietic dysfunction after chemotherapy alone or chemotherapy plus bone marrow transplantation
    Dierdorf, R
    Kreuter, U
    Jones, TC
    MEDICAL ONCOLOGY, 1997, 14 (02) : 91 - 98
  • [45] Use of granulocyte-macrophage colony stimulating factor in the treatment of prolonged haematopoietic dysfunction after chemotherapy alone or chemotherapy plus bone marrow transplantation
    Rainier Dierdorf
    Ulrich Kreuter
    Thomas C. Jones
    Medical Oncology, 1997, 14 : 91 - 98
  • [46] Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: A feasibility study
    Veldhuis, GJ
    Willemse, PHB
    Beijnen, JH
    Boonstra, H
    Piersma, H
    vanderGraaf, WTA
    deVries, EGE
    BRITISH JOURNAL OF CANCER, 1997, 75 (05) : 703 - 709
  • [47] EFFECTS OF GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON RESPIRATORY BURST ACTIVITY OF NEUTROPHILS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    OHSAKA, A
    KITAGAWA, S
    YUO, A
    MOTOYOSHI, K
    FURUSAWA, S
    MIURA, Y
    TAKAKU, F
    SAITO, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 91 (02) : 308 - 313
  • [48] Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice
    Hattori, K
    Orita, T
    Oheda, M
    Tamura, M
    Ono, M
    IN VIVO, 1996, 10 (03): : 319 - 327
  • [49] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCY
    MIWA, S
    SHIBATA, A
    KANEKO, T
    MORIYAMA, Y
    KAKU, K
    ISHIDA, Y
    TAKAHASHI, M
    ACTA HAEMATOLOGICA, 1992, 87 (1-2) : 22 - 28
  • [50] Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review
    Bohlius, J
    Reiser, M
    Schwarzer, G
    Engert, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 413 - 423
12345